Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid

Although glecaprevir/pibrentasvir (GP) therapy is recommended as a first-line treatment for hepatitis C virus (HCV) infection, serious drug-induced liver injury occasionally develops. The present study aimed to elucidate real-world risk factors for GP-induced liver injury and to evaluate the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamai, Hideyuki, Okamura, Jumpei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962642/
https://www.ncbi.nlm.nih.gov/pubmed/36851703
http://dx.doi.org/10.3390/v15020489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962642/
https://www.ncbi.nlm.nih.gov/pubmed/36851703
http://dx.doi.org/10.3390/v15020489

Ejemplares similares